SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-22-267201
Filing Date
2022-10-24
Accepted
2022-10-24 08:46:05
Documents
24
Period of Report
2022-10-24
Items
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d226370d8k.htm   iXBRL 8-K 48121
2 EX-99.1 d226370dex991.htm EX-99.1 32317
3 EX-99.2 d226370dex992.htm EX-99.2 11252
7 GRAPHIC g226370dfsp12020.jpg GRAPHIC 7487
8 GRAPHIC g226370ex99_2s1g1.jpg GRAPHIC 127423
9 GRAPHIC g226370ex99_2s2g1.jpg GRAPHIC 465884
10 GRAPHIC g226370ex99_2s3g1.jpg GRAPHIC 286843
11 GRAPHIC g226370ex99_2s4g1.jpg GRAPHIC 298594
12 GRAPHIC g226370ex99_2s5g1.jpg GRAPHIC 250914
13 GRAPHIC g226370ex99_2s6g1.jpg GRAPHIC 209514
14 GRAPHIC g226370ex99_2s7g1.jpg GRAPHIC 194248
15 GRAPHIC g226370ex99_2s8g1.jpg GRAPHIC 256721
16 GRAPHIC g226370ex99_2s9g1.jpg GRAPHIC 247011
  Complete submission text file 0001193125-22-267201.txt   3463195

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA mirm-20221024.xsd EX-101.SCH 2858
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE mirm-20221024_lab.xml EX-101.LAB 18739
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE mirm-20221024_pre.xml EX-101.PRE 11709
18 EXTRACTED XBRL INSTANCE DOCUMENT d226370d8k_htm.xml XML 3470
Mailing Address 950 TOWER LANE, SUITE 1050 FOSTER CITY CA 94404
Business Address 950 TOWER LANE, SUITE 1050 FOSTER CITY CA 94404 650-667-4085
Mirum Pharmaceuticals, Inc. (Filer) CIK: 0001759425 (see all company filings)

IRS No.: 831281555 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38981 | Film No.: 221324897
SIC: 2834 Pharmaceutical Preparations